Standing Order
Recursion Pharmaceuticals, Inc.

Dashboard

Recursion Pharmaceuticals, Inc.

RXRXNASDAQ

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$1.5B
Price$2.4552w $2.45 – $6.79
Conviction3/ 5
Revenue (TTM)$68M
Revenue growth YoY+56.7%
P/E (trailing)—
Gross margin10.7%
Operating margin-725.4%
Net margin-697.1%
52w price change-43.9%
Next earnings—

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

  • Nov 20
    OtherClinicalTrials.gov

    ClinicalTrials.gov update for NCT05985655 (GTAEXS617, Phase 1/2, advanced solid tumors): status changed to ACTIVE_NOT_RECRUITING; sponsored by Exscientia AI Ltd

  • Nov 18
    Ownership changeSEC

    Form 4 insider transaction filing.

  • Nov 18
    Ownership changeSEC

    Form 4 insider transaction filing reported.

  • Nov 18
    Ownership changeSEC

    Form 4 filing for change in beneficial ownership by insider at RXRX.

  • Nov 4
    Ownership changeSEC

    SEC Form 4 insider ownership change filing dated 2026-11-04.

  • Nov 4
    Ownership changeSEC

    SEC Form 4 insider ownership change filing.

  • Nov 2
    Financial resultsSEC

    8-K filing disclosing Q3 financial results (item 2.02) and leadership changes (item 5.02).

  • Oct 15
    Securities offeringSEC

    Recursion Pharmaceuticals filed Form 424B5 prospectus supplement.

  • Oct 15
    OtherSEC

    8-K filing covering items 1.01, 2.02, 7.01, 8.01, 9.01

  • Oct 15
    Securities offeringSEC

    Filed 424B5 prospectus supplement.

  • Oct 7
    Ownership changeSEC

    Form 4 insider ownership change filing dated 2026-10-07.

  • Oct 7
    Ownership changeSEC

    Form 4 insider transaction filing dated 2026-10-07.

  • Oct 2
    Ownership changeSEC

    Form 4 insider transaction filing.

  • Oct 2
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Sep 21
    DealSEC

    8-K item 1.01: entered into material definitive agreement.

  • Sep 16
    Ownership changeSEC

    Form 4 insider transaction filing.

  • Sep 10
    Ownership changeSEC

    Form 4 insider transaction filing.

  • Sep 2
    Ownership changeSEC

    Form 4 insider transaction filing.

  • Aug 18
    Ownership changeSEC

    Form 4 insider transaction filing.

  • Aug 18
    Ownership changeSEC

    Form 4 insider ownership change filing dated 2026-08-18.

Not financial advice — research and opinion only. Disclosures